WO2014108921A3 - Dispersion solide de phosphate de carvédilol - Google Patents

Dispersion solide de phosphate de carvédilol Download PDF

Info

Publication number
WO2014108921A3
WO2014108921A3 PCT/IN2014/000022 IN2014000022W WO2014108921A3 WO 2014108921 A3 WO2014108921 A3 WO 2014108921A3 IN 2014000022 W IN2014000022 W IN 2014000022W WO 2014108921 A3 WO2014108921 A3 WO 2014108921A3
Authority
WO
WIPO (PCT)
Prior art keywords
solid dispersion
carvedilol phosphate
pharmaceutically acceptable
phosphate solid
amorphous solid
Prior art date
Application number
PCT/IN2014/000022
Other languages
English (en)
Other versions
WO2014108921A2 (fr
Inventor
Bandi Parthasaradhi Reddy
Kura Rathnakar Reddy
Dasari Muralidhara Reddy
Kesireddy Subash Chander Reddy
Bandi Vamsi Krishna
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of WO2014108921A2 publication Critical patent/WO2014108921A2/fr
Publication of WO2014108921A3 publication Critical patent/WO2014108921A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention porte sur une nouvelle dispersion solide amorphe de phosphate de carvédilol en association avec un vecteur pharmaceutiquement acceptable, sur un procédé pour sa préparation et sur des compositions pharmaceutiques la comprenant.
PCT/IN2014/000022 2013-01-10 2014-01-09 Dispersion solide de phosphate de carvédilol WO2014108921A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ININ159/CHE/2013 2013-01-10
IN159CH2013 2013-01-10

Publications (2)

Publication Number Publication Date
WO2014108921A2 WO2014108921A2 (fr) 2014-07-17
WO2014108921A3 true WO2014108921A3 (fr) 2015-04-02

Family

ID=51167479

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000022 WO2014108921A2 (fr) 2013-01-10 2014-01-09 Dispersion solide de phosphate de carvédilol

Country Status (1)

Country Link
WO (1) WO2014108921A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286845A1 (en) * 2006-06-28 2009-11-19 Sigalit Levi Carvedilol phosphate
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090286845A1 (en) * 2006-06-28 2009-11-19 Sigalit Levi Carvedilol phosphate
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof

Also Published As

Publication number Publication date
WO2014108921A2 (fr) 2014-07-17

Similar Documents

Publication Publication Date Title
PH12015501595A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12015501598A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12016501122A1 (en) Delayed release compositions of linaclotide
WO2014076712A3 (fr) Dispersion solide de chlorhydrate de lurasidone
WO2015104658A3 (fr) Dispersion solide amorphe de dapagliflozine et procédé pour la préparation de dapagliflozine amorphe
PH12015501600A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MY188450A (en) Spiro-lactam nmda receptor modulators and uses thereof
EP3082817A4 (fr) Compositions pour administration de médicaments
WO2013134047A3 (fr) Dérivés d'aminoquinoléine et leurs utilisations
MX359288B (es) Forma iv del clorhidrato de ivabradina.
ZA201407021B (en) Novel thienopyrimidine derivatives,processes for the preparation thereof and therapeutic uses thereof
WO2013171764A3 (fr) Préparations ophtalmologiques
WO2013164839A3 (fr) Forme amorphe d'apixaban, son procédé de préparation et compositions de celle-ci
WO2014203275A3 (fr) Procédé amélioré pour la préparation d'apixaban et de ses intermédiaires
WO2014033526A9 (fr) Compositions pharmaceutiques d'étoricoxib
WO2015092810A3 (fr) Forme amorphe d'idélalisib
HK1197235A1 (zh) 二氫吡唑、其藥物組合物及其治療生育障礙的用途
WO2014009970A3 (fr) Dispersion solide de linagliptine
WO2014155389A3 (fr) Procédé de préparation de ticagrelor
WO2014145126A3 (fr) Méthodes de traitement de la dyskinésie et de troubles associés
EP2864328B8 (fr) Composés pharmaceutiquement actifs
WO2014115169A3 (fr) Dispersion solide de crizotinib
WO2015095659A3 (fr) Composition de dispersion solide d'indirubine
WO2015087343A3 (fr) Procédé amélioré pour la préparation de nilotinib et de sels pharmaceutiquement acceptables de celui-ci
WO2014013511A3 (fr) Dispersion solide de rufinamide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14738254

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 14738254

Country of ref document: EP

Kind code of ref document: A2